1. Clark TG, Bradburn MJ, Love SB, Altman DG. Survival analysis part I: basic concepts and first analyses. Br J Cancer. 2003;89(2):232-8. PMid:12865907. http://dx.doi.org/10.1038/sj.bjc.6601118.

2. Streiner DL. Stayin’alive: an introduction to survival analysis. Can J Psychiatry. 1995;40(8):439-44. PMid:8681267. http://dx.doi.org/10.1177/070674379504000804.

3. Botelho F, Silva C, Cruz F. Epidemiologia explicada–análise de sobrevivência. Acta Urol. 2009;26:33-8.

4. Bustamante-Teixeira MT, Faerstein E, Latorre MR. Técnicas de análise de sobrevida. Cad Saude Publica. 2002;18(3):579-94. PMid:12048585. http://dx.doi.org/10.1590/S0102-311X2002000300003.

5. Carvalho MS, Andreozzi VL, Codeço CT, Campos DP, Barbosa MTS, Shimakura SE. Análise de sobrevivência: teoria e aplicações em saúde. Rio de Janeiro: Editora FIOCRUZ; 2011.

6. Bastos J, Rocha C. Análise de sobrevivência: conceitos básicos. Arq Med. 2006;20:185-7.

7. Martinez RL, Naranjo JD. A pretest for choosing between logrank and wilcoxon tests in the two-sample problem. Metron. 2010;68(2):111-25. http://dx.doi.org/10.1007/BF03263529.

8. Ma J, Sun H, Chen SM. Clinical features and survival analysis of patients with CD20 positive adult B-lineage acute lymphoblastic leukemia. Journal of Experimental Hematology. 2010;18(2):477-81. PMid:20416193. http://dx.doi.org/10.1016/S1548-5315(11)70429-6.

9. Miot HA. Assessing normality of data in clinical and experimental trials. J Vasc Bras. 2017;16(2):88-91. http://dx.doi.org/10.1590/1677-5449.041117.

10. Altman DG, Bland JM. Time to event (survival) data. BMJ. 1998;317(7156):468-9. PMid:9703534. http://dx.doi.org/10.1136/bmj.317.7156.468.

11. Bradburn MJ, Clark TG, Love SB, Altman DG. Survival analysis part II: multivariate data analysis--an introduction to concepts and methods. Br J Cancer. 2003;89(3):431-6. PMid:12888808. http://dx.doi.org/10.1038/sj.bjc.6601119.

12. Schnohr P, Lange P, Nyboe J, Appleyard M, Jensen G. Gray hair, baldness, and wrinkles in relation to myocardial infarction: the Copenhagen City Heart Study. Am Heart J. 1995;130(5):1003-10. PMid:7484729. http://dx.doi.org/10.1016/0002-8703(95)90201-5.

13. Altman DG, De Stavola BL, Love SB, Stepniewska KA. Review of survival analyses published in cancer journals. Br J Cancer. 1995;72(2):511-8. PMid:7640241. http://dx.doi.org/10.1038/bjc.1995.364.

14. VanderWeele TJ, Tchetgen Tchetgen EJ, Halloran ME. Interference and Sensitivity Analysis. Stat Sci. 2014;29(4):687-706. PMid:25620841. http://dx.doi.org/10.1214/14-STS479.

15. Miot HA. Sample size in clinical and experimental trials. J Vasc Bras. 2011;10:275-8. http://dx.doi.org/10.1590/S1677-54492011000400001.

16. Williamson JM, Lin HM, Kim HY. Power and sample size calculations for current status survival analysis. Stat Med. 2009;28(15):1999-2011. PMid:19455509. http://dx.doi.org/10.1002/sim.3605.

17. Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics. 1983;39(2):499-503. PMid:6354290. http://dx.doi.org/10.2307/2531021.

18. Bagatin E, Miot HA. How to design and write a clinical research protocol in Cosmetic Dermatology. An Bras Dermatol. 2013;88(1):69-75. PMid:23539006. http://dx.doi.org/10.1590/S0365-05962013000100008